2022, Number 3
<< Back
Enf Infec Microbiol 2022; 42 (3)
COVID-19: a risk factor for mucormycosis and cryptococcosis. Case report
Durán QNC, Caro LJ, Gómez RJE, Pérez CRO, Zúñiga CIR
Language: Spanish
References: 10
Page: 142-145
PDF size: 213.83 Kb.
ABSTRACT
Mucormycosis is caused by opportunistic fungi belonging to the order Mucorales. It presents predisposingly in patients
with diabetes mellitus. We report the case of a 48-year-old woman, recently diagnosed diabetic with a history
of COVID-19 and extraction of an upper right molar; She later presented headache, right hemifacial edema, otalgia and
decreased visual acuity in the right eyeball, with paralysis of cranial nerves II, III, IV and VI. A culture was performed
that was positive for mucor and a nasal tissue biopsy with compatible images of cryptococcus.
REFERENCES
Ramphul, K., Verma, R., Kumar, N., Ramphul, Y., Mejias,S. y Lohana, P., “Rising concerns of mucormycosis (zygomycosis)among covid-19 patients: an analysis and reviewbased on case reports in literature”, Acta Biomed, 2021, 92 (4): e2021271. doi: 10.23750/abm.v92i4.11787.
Divakar, P.K., “Fungal taxa responsible for mucormycosis/‘black fungus’ among covid-19 patients in India”, JFungi (Basilea), 2021, 7 (8): 641.
Bayram, N., Ozsaygili, C., Sav, H., Tekin, Y., Gundogan,M., Pangal, E., Cicek, A. y Özcan, İ., “Susceptibility ofsevere covid-19 patients to rhino-orbital mucormycosisfungal infection in different clinical manifestations”, JpnJ Ophthalmol, 2021, 65 (4): 515-525.
Frías, M., Pinto, R., Hernández, R., García, E., Meza, P.,Rodríguez, C., Arenas, R., Conde, E., Acosta, G. y Martínez,E., “Epidemiology of systemic mycoses in thecovid-19 pandemic”, Journal Fungi, 2021, 7: 556.
Fauci, A., Kasper, D., Braunwald, E., Hauser, S., Longo,D., Jameson, J. y Loscalzo, J., Harrison: principios demedicina interna, México, McGraw-Hill, 2012.
Arenas, R., Dermatología. Atlas, diagnóstico y tratamiento,México, McGraw-Hill, 2019.
Fernández, J., Maselli, D., Simpson, T. y Restrepo, M.,“Pulmonary mucormycosis: what is the best strategyfor therapy?”, Respiratory Care, 2013, 58 (5): e60-e63.8.
Organización Panamericana de la Salud-OrganizaciónMundial de la Salud, “Alerta epidemiológica: mucormicosisasociada a covid-19”, 11 de junio de 2021, Washington,ops/oms, 2021.
Martín Gómez, M.T. y Salavert Lletí, M., “Mucormicosis:perspectiva de manejo actual y de futuro”, Rev IberoamMicol, 2021, 38 (2): 91-100.
Song, G., Liang, G. y Liu, W., “Fungal co-infections associatedwith global covid-19 pandemic: a clinical anddiagnostic perspective from China”, Mycopathologia,2020, 185 (4): 599-606.
Full text